Skip to main content
SpringerLink
Log in

Overview

  • Chapter
Aids-Associated Viral Oncogenesis

Part of the book series: Cancer Treatment and Research ((CTAR,volume 133))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal Wkly Rep 36(Suppl 1):1S–15S.

    Google Scholar 

  2. Update on acquired immune deficiency syndrome (AIDS)–United States. MMWR Morb Mortal Wkly Rep 31:507–8, 513–4.

    Google Scholar 

  3. Update: National Breast and Cervical Cancer Early Detection Program, July 1991–July 1992. MMWR Morb Mortal Wkly Rep 41:739–43.

    Google Scholar 

  4. Ahdieh-Grant, L., R. Li, A. M. Levine, L. S. Massad, H. D. Strickler, H. Minkoff, M. Moxley, J. Palefsky, H. Sacks, R. D. Burk, and S. J. Gange. 2004. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Natl Cancer Inst 96:1070–6.

    PubMed  CAS  Google Scholar 

  5. Ahdieh, L., R. S. Klein, R. Burk, S. Cu-Uvin, P. Schuman, A. Duerr, M. Safaeian, J. Astemborski, R. Daniel, and K. Shah. 2001. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 184:682–90.

    PubMed  CAS  Google Scholar 

  6. Ariyoshi, K., M. Schim van der Loeff, P. Cook, D. Whitby, T. Corrah, S. Jaffar, F. Cham, S. Sabally, D. O'Donovan, R. A. Weiss, T. F. Schulz, and H. Whittle. 1998. Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol 1:193–9.

    PubMed  CAS  Google Scholar 

  7. Beral, V. 1991. Epidemiology of Kaposi's sarcoma. Cancer Surv 10:5–22.

    PubMed  CAS  Google Scholar 

  8. Besson, C., A. Goubar, J. Gabarre, W. Rozenbaum, G. Pialoux, F. P. Chatelet, C. Katlama, F. Charlotte, B. Dupont, N. Brousse, M. Huerre, J. Mikol, P. Camparo, K. Mokhtari, M. Tulliez, D. Salmon-Ceron, F. Boue, D. Costagliola, and M. Raphael. 2001. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98:2339–44.

    PubMed  CAS  Google Scholar 

  9. Biggar, R. J. 2001. AIDS-related cancers in the era of highly active antiretroviral therapy. Oncology (Williston Park) 15:439–48; discussion 448–9.

    Google Scholar 

  10. Bosch, F. X., A. Lorincz, N. Munoz, C. J. Meijer, and K. V. Shah. 2002. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–65.

    PubMed  CAS  Google Scholar 

  11. Carbone, A. 2003. Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol 4:22–9.

    PubMed  CAS  Google Scholar 

  12. Carter, K. L., E. Cahir-McFarland, and E. Kieff. 2002. Epstein-Barr virus-induced changes in B-lymphocyte gene expression. J Virol 76:10427–36.

    PubMed  CAS  Google Scholar 

  13. Cesarman, E., Y. Chang, P. S. Moore, J. W. Said, and D. M. Knowles. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186–91.

    PubMed  CAS  Google Scholar 

  14. Chang, Y., E. Cesarman, M. S. Pessin, F. Lee, J. Culpepper, D. M. Knowles, and P. S. Moore. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865–9.

    PubMed  CAS  Google Scholar 

  15. Chiasson, M. A., T. V. Ellerbrock, T. J. Bush, X. W. Sun, and T. C. Wright, Jr. 1997. Increased prevalence of vulvovaginal condyloma and vulvar intraepithelial neoplasia in women infected with the human immunodeficiency virus. Obstet Gynecol 89:690–4.

    PubMed  CAS  Google Scholar 

  16. Chintu, C., U. H. Athale, and P. S. Patil. 1995. Childhood cancers in Zambia before and after the HIV epidemic. Arch Dis Child 73:100–4; discussion 104–5.

    Google Scholar 

  17. Cingolani, A., A. De Luca, L. M. Larocca, A. Ammassari, M. Scerrati, A. Antinori, and L. Ortona. 1998. Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. J Natl Cancer Inst 90:364–9.

    PubMed  CAS  Google Scholar 

  18. Cioc, A. M., C. Allen, J. R. Kalmar, S. Suster, R. Baiocchi, and G. J. Nuovo. 2004. Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol 28:41–6.

    PubMed  Google Scholar 

  19. Clifford, G. M., J. Polesel, M. Rickenbach, L. Dal Maso, O. Keiser, A. Kofler, E. Rapiti, F. Levi, G. Jundt, T. Fisch, A. Bordoni, D. De Weck, and S. Franceschi. 2005. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97:425–32.

    PubMed  Google Scholar 

  20. Cote, T. R., R. J. Biggar, P. S. Rosenberg, S. S. Devesa, C. Percy, F. J. Yellin, G. Lemp, C. Hardy, J. J. Geodert, and W. A. Blattner. 1997. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer 73:645–50.

    CAS  Google Scholar 

  21. Cote, T. R., A. Manns, C. R. Hardy, F. J. Yellin, and P. Hartge. 1996. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 88:675–9.

    CAS  Google Scholar 

  22. Delecluse, H. J., I. Anagnostopoulos, F. Dallenbach, M. Hummel, T. Marafioti, U. Schneider, D. Huhn, A. Schmidt-Westhausen, P. A. Reichart, U. Gross, and H. Stein. 1997. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 89:1413–20.

    PubMed  CAS  Google Scholar 

  23. Dilnur, P., H. Katano, Z. H. Wang, Y. Osakabe, M. Kudo, T. Sata, and Y. Ebihara. 2001. Classic type of Kaposi's sarcoma and human herpesvirus 8 infection in Xinjiang, China. Pathol Int 51:845–52.

    PubMed  CAS  Google Scholar 

  24. Dittmer, D. P., W. Vahrson, M. Staudt, C. Hilscher, and F. D. Fakhari. 2005. Kaposi's sarcoma in the era of HAART – an update on mechanisms, diagnostics and treatment. AIDS Rev 7:56–61.

    PubMed  Google Scholar 

  25. Doweiko, J., B. J. Dezube, and L. Pantanowitz. 2004. Unusual sites of Hodgkin's lymphoma: CASE 1. HIV-associated Hodgkin's lymphoma of the stomach. J Clin Oncol 22:4227–8.

    Google Scholar 

  26. Du, W., G. Chen, and H. Sun. 2000. Antibody to human herpesvirus type-8 in the general populations of Xinjiang Autonomous Region(A.R.). Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 14:44–6.

    PubMed  CAS  Google Scholar 

  27. Duerr, A., M. F. Sierra, J. Feldman, L. M. Clarke, I. Ehrlich, and J. DeHovitz. 1997. Immune compromise and prevalence of Candida vulvovaginitis in human immunodeficiency virus-infected women. Obstet Gynecol 90:252–6.

    PubMed  CAS  Google Scholar 

  28. Dupin, N., C. Fisher, P. Kellam, S. Ariad, M. Tulliez, N. Franck, E. van Marck, D. Salmon, I. Gorin, J. P. Escande, R. A. Weiss, K. Alitalo, and C. Boshoff. 1999. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci USA 96:4546–51.

    PubMed  CAS  Google Scholar 

  29. Durack, D. T. 1981. Opportunistic infections and Kaposi's sarcoma in homosexual men. N Engl J Med 305:1465–7.

    PubMed  CAS  Google Scholar 

  30. Edelman, D. C. 2005. Human herpesvirus 8–a novel human pathogen. Virol J 2:78.

    PubMed  Google Scholar 

  31. Ellerbrock, T. V., M. A. Chiasson, T. J. Bush, X. W. Sun, D. Sawo, K. Brudney, and T. C. Wright, Jr. 2000. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 283:1031–7.

    PubMed  CAS  Google Scholar 

  32. Franceschi, S., L. Dal Maso, S. Arniani, P. Crosignani, M. Vercelli, L. Simonato, F. Falcini, R. Zanetti, A. Barchielli, D. Serraino, and G. Rezza. 1998. Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS registry linkage study. Br J Cancer 78:966–70.

    CAS  Google Scholar 

  33. Friedman-Kien, A. E. 1981. Disseminated Kaposi's sarcoma syndrome in young homosexual men. J Am Acad Dermatol 5:468–71.

    PubMed  CAS  Google Scholar 

  34. Frisch, M., R. J. Biggar, E. A. Engels, and J. J. Goedert. 2001. Association of cancer with AIDS-related immunosuppression in adults. JAMA 285:1736–45.

    PubMed  CAS  Google Scholar 

  35. Gaidano, G., F. Lo Coco, B. H. Ye, D. Shibata, A. M. Levine, D. M. Knowles, and R. Dalla-Favera. 1994. Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype. Blood 84:397–402.

    PubMed  CAS  Google Scholar 

  36. Gallagher, B., Z. Wang, M. J. Schymura, A. Kahn, and E. J. Fordyce. 2001. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 154:544–56.

    PubMed  CAS  Google Scholar 

  37. Gao, S. J., L. Kingsley, M. Li, W. Zheng, C. Parravicini, J. Ziegler, R. Newton, C. R. Rinaldo, A. Saah, J. Phair, R. Detels, Y. Chang, and P. S. Moore. 1996. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 2:925–8.

    PubMed  CAS  Google Scholar 

  38. Gerard, L., L. Galicier, E. Boulanger, L. Quint, M. G. Lebrette, E. Mortier, V. Meignin, and E. Oksenhendler. 2003. Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy. AIDS 17:81–7.

    PubMed  CAS  Google Scholar 

  39. Gerard, L., L. Galicier, A. Maillard, E. Boulanger, L. Quint, S. Matheron, B. Cardon, V. Meignin, and E. Oksenhendler. 2002. Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival. J Acquir Immune Defic Syndr 30:478–84.

    PubMed  Google Scholar 

  40. Gill, P. S., Y. C. Tsai, A. P. Rao, C. H. Spruck, III, T. Zheng, W. A. Harrington, Jr., T. Cheung, B. Nathwani, and P. A. Jones. 1998. Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc Natl Acad Sci USA 95:8257–61.

    PubMed  CAS  Google Scholar 

  41. Giraldo, G., E. Beth, and E. S. Huang. 1980. Kaposi's sarcoma and its relationship to cytomegalovirus (CMNV). III. CMV DNA and CMV early antigens in Kaposi's sarcoma. Int J Cancer 26:23–9.

    CAS  Google Scholar 

  42. Glaser, S. L., C. A. Clarke, M. L. Gulley, F. E. Craig, J. A. DiGiuseppe, R. F. Dorfman, R. B. Mann, and R. F. Ambinder. 2003. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988–1998. Cancer 98:300–9.

    PubMed  Google Scholar 

  43. Goedert, J. J. 2000. The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 27:390–401.

    PubMed  CAS  Google Scholar 

  44. Goedert, J. J., T. R. Cote, P. Virgo, S. M. Scoppa, D. W. Kingma, M. H. Gail, E. S. Jaffe, and R. J. Biggar. 1998. Spectrum of AIDS-associated malignant disorders. Lancet 351:1833–9.

    PubMed  CAS  Google Scholar 

  45. Goedert, J. J., F. Vitale, C. Lauria, D. Serraino, M. Tamburini, M. Montella, A. Messina, E. E. Brown, G. Rezza, L. Gafa, and N. Romano. 2002. Risk factors for classical Kaposi's sarcoma. J Natl Cancer Inst 94:1712–8.

    PubMed  CAS  Google Scholar 

  46. Grulich, A. E. 1999. AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 21(Suppl 1):S27–30.

    PubMed  CAS  Google Scholar 

  47. Grulich, A. E., Y. Li, A. McDonald, P. K. Correll, M. G. Law, and J. M. Kaldor. 2002. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 16:1155–61.

    PubMed  Google Scholar 

  48. Grulich, A. E., Y. Li, A. M. McDonald, P. K. Correll, M. G. Law, and J. M. Kaldor. 2001. Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy. AIDS 15:629–33.

    PubMed  CAS  Google Scholar 

  49. Hartmann, P., U. Rehwald, B. Salzberger, C. Franzen, M. Sieber, A. Wohrmann, and V. Diehl. 2003. BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection. Ann Oncol 14:1562–9.

    PubMed  CAS  Google Scholar 

  50. He, J., G. Bhat, C. Kankasa, C. Chintu, C. Mitchell, W. Duan, and C. Wood. 1998. Seroprevalence of human herpesvirus 8 among Zambian women of childbearing age without Kaposi's sarcoma (KS) and mother–child pairs with KS. J Infect Dis 178:1787–90.

    PubMed  CAS  Google Scholar 

  51. Heard, I., V. Schmitz, D. Costagliola, G. Orth, and M. D. Kazatchkine. 1998. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 12:1459–64.

    PubMed  CAS  Google Scholar 

  52. Heard, I., J. M. Tassie, V. Schmitz, L. Mandelbrot, M. D. Kazatchkine, and G. Orth. 2000. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1). Obstet Gynecol 96:403–9.

    PubMed  CAS  Google Scholar 

  53. Hengge, U. R., T. Ruzicka, S. K. Tyring, M. Stuschke, M. Roggendorf, R. A. Schwartz, and S. Seeber. 2002. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2:281–92.

    PubMed  Google Scholar 

  54. Hillemanns, P., T. V. Ellerbrock, S. McPhillips, P. Dole, S. Alperstein, D. Johnson, X. W. Sun, M. A. Chiasson, and T. C. Wright, Jr. 1996. Prevalence of anal human papillomavirus infection and anal cytologic abnormalities in HIV-seropositive women. AIDS 10:1641–7.

    PubMed  CAS  Google Scholar 

  55. Hoffmann, C., K. U. Chow, E. Wolf, G. Faetkenheuer, H. J. Stellbrink, J. van Lunzen, H. Jaeger, A. Stoehr, A. Plettenberg, J. C. Wasmuth, J. Rockstroh, F. Mosthaf, H. A. Horst, and H. R. Brodt. 2004. Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease. Br J Haematol 125:455–62.

    PubMed  Google Scholar 

  56. Hoffmann, C., S. Tabrizian, E. Wolf, C. Eggers, A. Stoehr, A. Plettenberg, T. Buhk, H. J. Stellbrink, H. A. Horst, H. Jager, and T. Rosenkranz. 2001. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 15:2119–27.

    PubMed  CAS  Google Scholar 

  57. Iscovich, J., P. Boffetta, S. Franceschi, E. Azizi, and R. Sarid. 2000. Classic Kaposi sarcoma: epidemiology and risk factors. Cancer 88:500–17.

    PubMed  CAS  Google Scholar 

  58. Jacobson, L. P., T. E. Yamashita, R. Detels, J. B. Margolick, J. S. Chmiel, L. A. Kingsley, S. Melnick, and A. Munoz. 1999. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 21(Suppl 1):S34–41.

    CAS  Google Scholar 

  59. Jones, J. L., D. L. Hanson, M. S. Dworkin, and H. W. Jaffe. 2000. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. J Acquir Immune Defic Syndr 24:270–4.

    PubMed  CAS  Google Scholar 

  60. Kaplan, L. D., J. Y. Lee, R. F. Ambinder, J. A. Sparano, E. Cesarman, A. Chadburn, A. M. Levine, and D. T. Scadden. 2005. Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood 106:1538–43.

    PubMed  CAS  Google Scholar 

  61. Kaplan, L. D., D. J. Straus, M. A. Testa, J. Von Roenn, B. J. Dezube, T. P. Cooley, B. Herndier, D. W. Northfelt, J. Huang, A. Tulpule, and A. M. Levine. 1997. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 336:1641–8.

    CAS  Google Scholar 

  62. Kaposi, M. 1872. Arch Dermatol Syphilis 4:265–73.

    Google Scholar 

  63. Katz, M. H., N. A. Hessol, S. P. Buchbinder, A. Hirozawa, P. O'Malley, and S. D. Holmberg. 1994. Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. J Infect Dis 170:198–202.

    PubMed  CAS  Google Scholar 

  64. Keller, S. A., E. J. Schattner, and E. Cesarman. 2000. Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 96:2537–42.

    PubMed  CAS  Google Scholar 

  65. Kelly, G. L., A. E. Milner, R. J. Tierney, D. S. Croom-Carter, M. Altmann, W. Hammerschmidt, A. I. Bell, and A. B. Rickinson. 2005. Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis. J Virol 79:10709–17.

    PubMed  CAS  Google Scholar 

  66. Kirk, O., C. Pedersen, A. Cozzi-Lepri, F. Antunes, V. Miller, J. M. Gatell, C. Katlama, A. Lazzarin, P. Skinhoj, and S. E. Barton. 2001. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 98:3406–12.

    PubMed  CAS  Google Scholar 

  67. Klein, U., A. Gloghini, G. Gaidano, A. Chadburn, E. Cesarman, R. Dalla-Favera, and A. Carbone. 2003. Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood 101:4115–21.

    PubMed  CAS  Google Scholar 

  68. Knowles, D. M. 2003. Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 17:785–820.

    PubMed  Google Scholar 

  69. Krishnan, A., A. Molina, J. Zaia, D. Smith, D. Vasquez, N. Kogut, P. M. Falk, J. Rosenthal, J. Alvarnas, and S. J. Forman. 2005. Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood 105:874–8.

    PubMed  CAS  Google Scholar 

  70. Kurokawa, M., S. K. Ghosh, J. C. Ramos, A. M. Mian, N. L. Toomey, L. Cabral, D. Whitby, G. N. Barber, D. P. Dittmer, and W. J. Harrington, Jr. 2005. Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma. Blood 106:235–40.

    PubMed  CAS  Google Scholar 

  71. Lebbe, C., L. Blum, C. Pellet, G. Blanchard, O. Verola, P. Morel, O. Danne, and F. Calvo. 1998. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS 12:F45–9.

    PubMed  CAS  Google Scholar 

  72. Levine, A. M. 2002. Challenges in the management of Burkitt's lymphoma. Clin Lymphoma 3(Suppl 1): S19–25.

    PubMed  Google Scholar 

  73. Levine, A. M., P. Li, T. Cheung, A. Tulpule, J. Von Roenn, B. N. Nathwani, and L. Ratner. 2000. Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149). J Acquir Immune Defic Syndr 24:444–50.

    PubMed  CAS  Google Scholar 

  74. Levine, A. M., L. Seneviratne, B. M. Espina, A. R. Wohl, A. Tulpule, B. N. Nathwani, and P. S. Gill. 2000. Evolving characteristics of AIDS-related lymphoma. Blood 96:4084–90.

    PubMed  CAS  Google Scholar 

  75. Li, J. J., Y. Q. Huang, C. J. Cockerell, and A. E. Friedman-Kien. 1996. Localization of human herpes-like virus type 8 in vascular endothelial cells and perivascular spindle-shaped cells of Kaposi's sarcoma lesions by in situ hybridization. Am J Pathol 148:1741–8.

    PubMed  CAS  Google Scholar 

  76. Lillo, F. B., D. Ferrari, F. Veglia, M. Origoni, M. A. Grasso, S. Lodini, E. Mastrorilli, G. Taccagni, A. Lazzarin, and C. Uberti-Foppa. 2001. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 184:547–51.

    PubMed  CAS  Google Scholar 

  77. Lim, S. T., R. Karim, B. N. Nathwani, A. Tulpule, B. Espina, and A. M. Levine. 2005. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J Clin Oncol 23:4430–8.

    PubMed  CAS  Google Scholar 

  78. Massad, L. S., L. Ahdieh, L. Benning, H. Minkoff, R. M. Greenblatt, H. Watts, P. Miotti, K. Anastos, M. Moxley, L. I. Muderspach, and S. Melnick. 2001. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study. J Acquir Immune Defic Syndr 27:432–42.

    PubMed  CAS  Google Scholar 

  79. Massad, L. S., K. A. Riester, K. M. Anastos, R. G. Fruchter, J. M. Palefsky, R. D. Burk, D. Burns, R. M. Greenblatt, L. I. Muderspach, and P. Miotti. 1999. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquir Immune Defic Syndr 21:33–41.

    CAS  Google Scholar 

  80. Mbulaiteye, S. M., R. J. Biggar, J. J. Goedert, and E. A. Engels. 2002. Pleural and peritoneal lymphoma among people with AIDS in the United States. J Acquir Immune Defic Syndr 29:418–21.

    PubMed  Google Scholar 

  81. McGowan, J. P., and S. Shah. 1998. Long-term remission of AIDS-related primary central nervous system lymphoma associated with highly active antiretroviral therapy. AIDS 12:952–4.

    PubMed  CAS  Google Scholar 

  82. Minkoff, H., L. Ahdieh, L. S. Massad, K. Anastos, D. H. Watts, S. Melnick, L. Muderspach, R. Burk, and J. Palefsky. 2001. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 15:2157–64.

    PubMed  CAS  Google Scholar 

  83. Minkoff, H. L., D. Eisenberger-Matityahu, J. Feldman, R. Burk, and L. Clarke. 1999. Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus. Am J Obstet Gynecol 180:824–36.

    PubMed  CAS  Google Scholar 

  84. Mocroft, A., C. Katlama, A. M. Johnson, C. Pradier, F. Antunes, F. Mulcahy, A. Chiesi, A. N. Phillips, O. Kirk, and J. D. Lundgren. 2000. AIDS across Europe, 1994–98: the EuroSIDA study. Lancet 356:291–6.

    PubMed  CAS  Google Scholar 

  85. Newell, M. E., J. F. Hoy, S. G. Cooper, B. DeGraaff, A. E. Grulich, M. Bryant, J. L. Millar, B. J. Brew, and D. I. Quinn. 2004. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients. Cancer 100:2627–36.

    PubMed  Google Scholar 

  86. Olsen, S. J., Y. Chang, P. S. Moore, R. J. Biggar, and M. Melbye. 1998. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS 12:1921–5.

    PubMed  CAS  Google Scholar 

  87. Palefsky, J. M. 2003. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol 15:382–8.

    PubMed  Google Scholar 

  88. Pellett, P. E., D. J. Wright, E. A. Engels, D. V. Ablashi, S. C. Dollard, B. Forghani, S. A. Glynn, J. J. Goedert, F. J. Jenkins, T. H. Lee, F. Neipel, D. S. Todd, D. Whitby, G. J. Nemo, and M. P. Busch. 2003. Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion 43:1260–8.

    PubMed  CAS  Google Scholar 

  89. Piketty, C., T. M. Darragh, M. Da Costa, P. Bruneval, I. Heard, M. D. Kazatchkine, and J. M. Palefsky. 2003. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 138:453–9.

    PubMed  Google Scholar 

  90. Powles, T., G. Matthews, and M. Bower. 2000. AIDS related systemic non-Hodgkin's lymphoma. Sex Transm Infect 76:335–41.

    PubMed  CAS  Google Scholar 

  91. Rabkin, C. S. 2001. AIDS and cancer in the era of highly active antiretroviral therapy (HAART). Eur J Cancer 37:1316–9.

    PubMed  CAS  Google Scholar 

  92. Rabkin, C. S., M. A. Testa, J. Huang, and J. H. Von Roenn. 1999. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants. J Acquir Immune Defic Syndr 21(Suppl 1):S31–3.

    PubMed  CAS  Google Scholar 

  93. Raez, L., L. Cabral, J. P. Cai, H. Landy, G. Sfakianakis, G. E. Byrne, Jr., J. Hurley, E. Scerpella, D. Jayaweera, and W. J. Harrington, Jr. 1999. Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2. AIDS Res Hum Retroviruses 15:713–9.

    PubMed  CAS  Google Scholar 

  94. Ratner, L., J. Lee, S. Tang, D. Redden, F. Hamzeh, B. Herndier, D. Scadden, L. Kaplan, R. Ambinder, A. Levine, W. Harrington, L. Grochow, C. Flexner, B. Tan, and D. Straus. 2001. Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 19:2171–8.

    PubMed  CAS  Google Scholar 

  95. Re, A., C. Cattaneo, M. Michieli, S. Casari, M. Spina, M. Rupolo, B. Allione, A. Nosari, C. Schiantarelli, M. Vigano, I. Izzi, P. Ferremi, A. Lanfranchi, M. Mazzuccato, G. Carosi, U. Tirelli, and G. Rossi. 2003. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol 21:4423–7.

    PubMed  CAS  Google Scholar 

  96. Roizman, B., R. C. Desrosiers, B. Fleckenstein, C. Lopez, A. C. Minson, and M. J. Studdert. 1992. The family Herpesviridae: an update. Arch Virol 123:425–49.

    Google Scholar 

  97. Rooney, C. M., M. A. Roskrow, C. A. Smith, M. K. Brenner, and H. E. Heslop. 1998. Immunotherapy for Epstein-Barr virus-associated cancers. J Natl Cancer Inst Monogr 23:89–93.

    PubMed  CAS  Google Scholar 

  98. Roychowdhury, S., R. Peng, R. A. Baiocchi, D. Bhatt, S. Vourganti, J. Grecula, N. Gupta, C. F. Eisenbeis, G. J. Nuovo, W. Yang, P. Schmalbrock, A. Ferketich, M. Moeschberger, P. Porcu, R. F. Barth, and M. A. Caligiuri. 2003. Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma. Cancer Res 63:965–71.

    PubMed  CAS  Google Scholar 

  99. Scadden, D. T. 2003. AIDS-related malignancies. Annu Rev Med 54:285–303.

    PubMed  CAS  Google Scholar 

  100. Schulz, T. F. 2000. KSHV (HHV8) infection. J Infect 41:125–9.

    PubMed  CAS  Google Scholar 

  101. Schuman, P., S. E. Ohmit, R. S. Klein, A. Duerr, S. Cu-Uvin, D. J. Jamieson, J. Anderson, and K. V. Shah. 2003. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 188:128–36.

    PubMed  Google Scholar 

  102. Serraino, D. 1999. The spectrum of AIDS-associated cancers in Africa. AIDS 13:2589–90.

    PubMed  CAS  Google Scholar 

  103. Shibata, D., L. M. Weiss, A. M. Hernandez, B. N. Nathwani, L. Bernstein, and A. M. Levine. 1993. Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood 81:2102–9.

    PubMed  CAS  Google Scholar 

  104. Simon, V., D. D. Ho, and Q. Abdool Karim. 2006. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 368:489–504.

    PubMed  Google Scholar 

  105. Spina, M., M. Berretta, and U. Tirelli. 2003. Hodgkin's disease in HIV. Hematol Oncol Clin North Am 17:843–58.

    PubMed  Google Scholar 

  106. Spina, M., and U. Tirelli. 2004. HIV-related non-Hodgkin's lymphoma (HIV-NHL) in the era of highly active antiretroviral therapy (HAART): some still unanswered questions for clinical management. Ann Oncol 15:993–5.

    PubMed  CAS  Google Scholar 

  107. Stebbing, J., V. Marvin, and M. Bower. 2004. The evidence-based treatment of AIDS-related non-Hodgkin's lymphoma. Cancer Treat Rev 30:249–53.

    PubMed  Google Scholar 

  108. Straus, D. J. 2001. HIV-associated lymphomas. Curr Oncol Rep 3:260–5.

    PubMed  CAS  Google Scholar 

  109. Strickler, H. D., R. D. Burk, M. Fazzari, K. Anastos, H. Minkoff, L. S. Massad, C. Hall, M. Bacon, A. M. Levine, D. H. Watts, M. J. Silverberg, X. Xue, N. F. Schlecht, S. Melnick, and J. M. Palefsky. 2005. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 97:577–86.

    Article  PubMed  Google Scholar 

  110. Sun, X. W., J. P. Koulos, J. C. Felix, A. Ferenczy, R. M. Richart, T. W. Park, and T. O. Wright, Jr. 1995. Human papillomavirus testing in primary cervical screening. Lancet 346:636.

    PubMed  CAS  Google Scholar 

  111. Sun, X. W., L. Kuhn, T. V. Ellerbrock, M. A. Chiasson, T. J. Bush, and T. C. Wright, Jr. 1997. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 337:1343–9.

    PubMed  CAS  Google Scholar 

  112. Tam, H. K., Z. F. Zhang, L. P. Jacobson, J. B. Margolick, J. S. Chmiel, C. Rinaldo, and R. Detels. 2002. Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma. Int J Cancer 98:916–22.

    PubMed  CAS  Google Scholar 

  113. Teruya-Feldstein, J., E. Chiao, D. A. Filippa, O. Lin, R. Comenzo, M. Coleman, C. Portlock, and A. Noy. 2004. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 15:1673–9.

    PubMed  CAS  Google Scholar 

  114. UNAIDS. 2006. Report on the global AIDS epidemic: a UNAIDS 10th anniversary special edition. http://www.unaids.org/en/HIV_data/2006GlobalReport/default.asp

  115. Vaccher, E., M. Spina, and U. Tirelli. 2001. Clinical aspects and management of Hodgkin's disease and other tumours in HIV-infected individuals. Eur J Cancer 37:1306–15.

    PubMed  CAS  Google Scholar 

  116. van Baarle, D., E. Hovenkamp, M. F. Callan, K. C. Wolthers, S. Kostense, L. C. Tan, H. G. Niesters, A. D. Osterhaus, A. J. McMichael, M. H. van Oers, and F. Miedema. 2001. Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma. Blood 98:146–55.

    PubMed  Google Scholar 

  117. Wabinga, H. R., D. M. Parkin, F. Wabwire-Mangen, and J. W. Mugerwa. 1993. Cancer in Kampala, Uganda, in 1989–91: changes in incidence in the era of AIDS. Int J Cancer 54:26–36.

    PubMed  CAS  Google Scholar 

  118. Waggoner, S. E. 2003. Cervical cancer. Lancet 361:2217–25.

    PubMed  Google Scholar 

  119. Yarchoan, R., G. Tosato, and R. F. Little. 2005. Therapy insight: AIDS-related malignancies – the influence of antiviral therapy on pathogenesis and management. Nat Clin Pract Oncol 2:406–15; quiz 423.

    Google Scholar 

  120. Young, L., C. Alfieri, K. Hennessy, H. Evans, C. O'Hara, K. C. Anderson, J. Ritz, R. S. Shapiro, A. Rickinson, E. Kieff, et al. 1989. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321:1080–5.

    PubMed  CAS  Google Scholar 

  121. Young, L. S., and A. B. Rickinson. 2004. Epstein-Barr virus: 40 years on. Nat Rev Cancer 4:757–68.

    PubMed  CAS  Google Scholar 

  122. Ziegler, J. L., J. A. Beckstead, P. A. Volberding, D. I. Abrams, A. M. Levine, R. J. Lukes, P. S. Gill, R. L. Burkes, P. R. Meyer, C. E. Metroka, et al. 1984. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 311:565–70.

    CAS  Google Scholar 

  123. zur Hausen, H., L. Gissmann, W. Steiner, W. Dippold, and I. Dreger. 1975. Human papilloma viruses and cancer. Bibl Haematol 43:569–71.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nebraska Center for Virology, and the School of Biological Sciences, University of Nebraska, Lincoln, NE

    Charles Wood Ph.D.

Authors
  1. Charles Wood Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

C. Meyers

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Wood, C. (2007). Overview. In: Meyers, C. (eds) Aids-Associated Viral Oncogenesis. Cancer Treatment and Research, vol 133. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-46816-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-46816-7_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-46804-4

  • Online ISBN: 978-0-387-46816-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation